REPORTS

Let’s Pullulate and Expand Your Business

Urokinase Market - Global Professional Analysis and Forecast to 2026

Nov 03, 2019  |  143 PAGES  |  REPORT CODE: CMM227276
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Urokinase market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.5% during the forecast period.

This report presents the market size and development trends by detailing the Urokinase market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Urokinase market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Urokinase industry and will help you to build a panoramic view of the industrial development.

Urokinase Market, By Type:

  • Injection

  • Freeze-dried powder

Urokinase Market, By Application:

  • Hospital use

  • Clinic

  • Others

Some of the leading players are as follows:

  • Mylan

  • Tianjin Biochem Pharmaceutical

  • NDPHARM

  • Zydus Cadila

  • Abbott

  • Suzhou No.1 Pharmaceutical

  • Takeda

  • Mayne Pharma Inc

  • Squibb

  • JCR Pharmaceuticals

  • Microbix Biosystems Inc

  • Taj Pharma

  • PKU High-Tech Huatai Pharmaceutica

  • Liaoning Weixing Pharmaceutical

  • Livzon Pharmaceutical Group

  • Emcure

  • Bharat Biotech

  • Teva

  • United Biotech

  • Pfizer

  • Sandoz

  • Novartis

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Urokinase Market: Technology Type Analysis

  • 4.1 Urokinase Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Urokinase Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Injection

    • 4.3.2 Freeze-dried powder

5 Urokinase Market: Product Analysis

  • 5.1 Urokinase Product Market Share Analysis, 2018 & 2026

  • 5.2 Urokinase Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Urokinase Market: Application Analysis

  • 6.1 Urokinase Application Market Share Analysis, 2018 & 2026

  • 6.2 Urokinase Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital use

    • 6.3.2 Clinic

    • 6.3.3 Others

7 Urokinase Market: Regional Analysis

  • 7.1 Urokinase Regional Market Share Analysis, 2018 & 2026

  • 7.2 Urokinase Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Mylan

    • 9.1.1 Mylan Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Tianjin Biochem Pharmaceutical

    • 9.2.1 Tianjin Biochem Pharmaceutical Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 NDPHARM

    • 9.3.1 NDPHARM Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Zydus Cadila

    • 9.4.1 Zydus Cadila Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Abbott

    • 9.5.1 Abbott Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Suzhou No.1 Pharmaceutical

    • 9.6.1 Suzhou No.1 Pharmaceutical Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Takeda

    • 9.7.1 Takeda Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Mayne Pharma Inc

    • 9.8.1 Mayne Pharma Inc Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Squibb

    • 9.9.1 Squibb Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 JCR Pharmaceuticals

    • 9.10.1 JCR Pharmaceuticals Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Microbix Biosystems Inc

    • 9.11.1 Microbix Biosystems Inc Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Taj Pharma

    • 9.12.1 Taj Pharma Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 PKU High-Tech Huatai Pharmaceutica

    • 9.13.1 PKU High-Tech Huatai Pharmaceutica Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Liaoning Weixing Pharmaceutical

    • 9.14.1 Liaoning Weixing Pharmaceutical Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Livzon Pharmaceutical Group

    • 9.15.1 Livzon Pharmaceutical Group Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Emcure

    • 9.16.1 Emcure Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Bharat Biotech

    • 9.17.1 Bharat Biotech Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Teva

    • 9.18.1 Teva Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 United Biotech

    • 9.19.1 United Biotech Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Pfizer

    • 9.20.1 Pfizer Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Sandoz

    • 9.21.1 Sandoz Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Novartis

    • 9.22.1 Novartis Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

 

The List of Tables and Figures (Totals 72 Figures and 154 Tables)

  • Figure Injection Urokinase market, 2015 - 2026 (USD Million)

  • Figure Freeze-dried powder Urokinase market, 2015 - 2026 (USD Million)

  • Figure Hospital use market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Urokinase market, by country, 2015 - 2026 (USD Million)

  • Table North America Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table North America Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table North America Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Canada Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Canada Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Europe Urokinase market, by country, 2015 - 2026 (USD Million)

  • Table Europe Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Europe Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Europe Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Germany Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Germany Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table France Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table France Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Italy Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Italy Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Spain Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Spain Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Urokinase market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table China Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table China Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Japan Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Japan Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table India Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table India Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Urokinase market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table MEA Urokinase market, by country, 2015 - 2026 (USD Million)

  • Table MEA Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table MEA Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table MEA Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Urokinase market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Urokinase market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Urokinase market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tianjin Biochem Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NDPHARM Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zydus Cadila Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Suzhou No.1 Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takeda Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mayne Pharma Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table JCR Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Microbix Biosystems Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Taj Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PKU High-Tech Huatai Pharmaceutica Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Liaoning Weixing Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Livzon Pharmaceutical Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emcure Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bharat Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table United Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sandoz Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top